Public SEC Form D records
Biotech Form D filings - September 2026
This page lists the 13 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers in September 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 13
- Issuers
- 13
- Combined disclosed
- $338.4M
Directory links
Filing records
13 crawlable filing links in this facet.
- Cloverleaf Bio, Inc.September 9, 2026 / Reg D 506(b) / CT$29.6M
- Klothea Bio, Inc.September 8, 2026 / Reg D 506(b) / FL$10.4M
- JUPITER NEUROSCIENCES, INC.September 4, 2026 / Reg D 506(b) / FL$774.8K
- Gossamer Bio, Inc.September 4, 2026 / Reg D 506(b) / CA$150.0M
- Dravite Therapeutics, Inc.September 3, 2026 / Reg D 506(b) / CA$53.0M
- Superluminal Medicines, Inc.September 3, 2026 / Reg D 506(b) / MA$65.5M
- Sensible Biotechnologies, Inc.September 2, 2026 / Reg D 506(b)$15.0M
- Agen Genomics, Inc.September 2, 2026 / Reg D 506(b) / CA$1.5M
- Telemachus Therapeutics, Inc.September 2, 2026 / Reg D 506(b) / PA$1.5M
- Aclarity Genomics, Inc.September 2, 2026 / Reg D 506(b) / NC$4.6M
- CYBIN INC.September 1, 2026 / Reg D 506(b)$262.0K
- Kaida BioPharma Inc.September 1, 2026 / Reg D 506(b) / FL$4.1M
- Voxcell BioInnovation Inc.September 1, 2026 / Reg D 506(b)$2.2M